Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study

Japanese Journal of Clinical Oncology

Volumn 36, Issue 10, 2006, Pages 655-661

  Morishima, Yasuo ^a   Ogura, Michinori ^a   Yoneda, Shuichi ^b   Sakai, Hiroshi ^b   Tobinai, Kensei ^c   Nishiwaki, Yutaka ^d   Minami, Hironobu ^d   Hotta, Tomomitsu ^e   Ezaki, Kohji ^f   Ohe, Yuichiro ^c   Yokoyama, Akira ^g   Tsuboi, Masahiro ^h   Mori, Kiyoshi ⁱ   Watanabe, Koshiro ^j   Ohashi, Yasuo ^k   Hirashima, Kunitake ^l   Saijo, Nagahiro ^d  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NIIGATA CANCER CENTER HOSPITAL   (Japan)

^h TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

ⁱ TOCHIGI CANCER CENTER   (Japan)

^j YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^k UNIVERSITY OF TOKYO   (Japan)

^l SAITAMA MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Chemotherapy induced anemia; Erythropoietin; Lung cancer; Malignant lymphoma; Quality of life

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; IRON; METHYLPREDNISOLONE; PLATINUM COMPLEX; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; TAXANE DERIVATIVE; VINCRISTINE;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DIARRHEA; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FEVER; FUNCTIONAL ASSESSMENT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; LEUKOPENIA; LIVER DYSFUNCTION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PURE RED CELL ANEMIA; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA;

ADULT; AGED; ANEMIA; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRIDGED COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; LEUKOPENIA; LUNG NEOPLASMS; LYMPHOMA; MALE; MIDDLE AGED; PLATINUM COMPOUNDS; QUALITY OF LIFE; TAXOIDS;

EID: 33750734368     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl097     Document Type: Article

References (23)

1. Bron D, Meuleman N, Mascaux C. Biological basis of anemia. Semin Oncol 2001;28(2 suppl 8):1-6.
2. Sasaki H, Bothner B, Dell A, Fukuda M. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 1987; 262:12059-76.
3. Okamoto H, Saijo N, Shinkai T, Eguchi K, Sasaki Y, Tamura T, et al. Chemotherapy-induced anemia in patients with primary lung cancer. Ann Oncol 1992;3:819-24.
4. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: Incidence and treatment. J Natl Cancer Inst 1999;91:1616-34.
5. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer. Cancer 2001;91:2214-21.
6. Kunikane H, Watanabe K, Fukuoka M, Saijo N, Furuse K, Ikegami H, et al. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer. Int J Clin Oncol 2001;6:296-301.
7. Seidenfeld J, Piper M, Flamm C, Hasselblad V, Armitage JO, Bennett CL, et al. Epoetin treatment of anemia associated with cancer therapy: A systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst 2001;93:1204-14.
8. Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennett C, et al. Recombinant human erythropoietin and overall survival in cancer patients: Results of a comprehensive meta-analysis. J Natl Cancer Inst 2005;97:489-98.
9. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-74.
10. Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times weekly dosing. J Clin Oncol 2001;19:2875-82.
11. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. J Clin Oncol 1998;16:3412-25.
12. Cazzola M, Beguin Y, Kloczko J, Spicka I, Coiffier B. Once-weekly epoetin-beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production. Br J Haematol 2003;122:386-93.
13. Yoshimura A, Kobayashi K, Fumimoto H, Fujiki Y, Eremenco S, Kudoh S. Cross-cultural validation of the Japanese Functional Assessment of Cancer Therapy-Anemia (FACT-An). J Nippon Med Sch 2004;71:314-22.
14. Dunnett CW, Tamhane AC. Multiple testing to establish superiority/ equivalence of a new treatment compared with kappa standard treatments. Stat Med 1997;16:2489-506.
15. Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, et al. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 2005;23:2606-17.
16. Chang J, Couture F, Young S, Mcwatters KL, Lau CY. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol 2005;23:2597-605.
17. Boogaerts M, Coiffier B, Kainz C, Epoetin beta QOL Working Group. Impact of epoetin-beta on quality of life in patients with malignant disease. Br J Cancer 2003;88:988-95.
18. Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JW. Epoetin alfa treatment results in clinically significant improvements in quality of life on anemic cancer patients when referenced to the general population. J Clin Oncol 2003;21:366-73.
19. Osterborg A, Brandberg Y, Molostova V, Iosava G, Abdulkadyrov K, Hedenus M, et al. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin-beta in hematologic malignancies. J Clin Oncol 2002;20:2486-94.
20. Hedenus M, Adriansson M, San Miguel J, Kramer MH, Schipperus MR, Juvonen E, et al. Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: A randomized, double-blind, placebo-controlled study. Br J Haematol 2003;122:394-403.
21. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, et al. Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002;20:4083-107.
22. Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-60.
23. Leyland-Jones B. BEST Investigators and Study Group. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003;4:459-60.